Replies to post #29920 on Amarin Corp Plc (AMRN)

[Biobillionair]

I'm waiting for confirmation that Jenkins answer is no reinstatement, from there I decide. Waiting....again.

All signs point to no change in the FDA stance.

[birzinho]

JPSeb,
early today i posted the following, give it a look maybe it has a connection with the supposed news that determined the umpteen change of mood of BB.

Did anyone notice the Jefferies Report posted on june 20th by Keystone on YMB? I was mumbling over the (highlighted) comment regarding the FDA stubborness: IMO it sounds a little bit strange, as it was not needed in the contest of the news.

It makes me think they may know something we don't. Surely at this point in time something is happened (news about possible meeting FDA/Amarin; some kind of communications between them took already place; they may have updated feelings on the FDA sentiment)
B.


Jefferies Report - June 19, 2014

Amarin Corporation (AMRN)?NEJM Articles on Benefits of Triglyceride?Reductions Is a Positive for Vascepa??Key Takeaway?
In this week’s New England Journal of Medicine, two articles show a strong?correlation between reduced triglyceride levels and reduced cardiovascular?risk. Uncertainty on the correlation of these two variables led to a FDA panel?rejecting Vascepa approval in the ANCHOR indication. We see these data as a?positive for AMRN. We still see the FDA likely to be stubborn in its insistence on REDUCE-IT outcomes study, but we have increased confidence in REDUCE-IT.